Adverse effects of anticoagulation treatment: clinically significant upper gastrointestinal hemorrhage

Adverse effects of anticoagulation treatment: clinically significant upper gastrointestinal hemorrhage

Blog Article

Background: Over the last years, the use of oral anticoagulant treatment has increased dramatically, principally for the prevention of venous kicker pro comp 10 thrombosis and thrombembolic events.This treatment is demanding, especially among the elderly with concommitant diseases and different medication.Aim of the study to evaluate the rate of serious complications, clinically significant hemorrhage from upper gastointestinal tract in patients treated with oral antiocoagulants in a prospective cohort study.Patients and methods: Included were patients admitted to our institution between January 1, 1994 and December 31, 2003 due to gastrointestinal hemorrhage.

Emergency endoscopy and laboratory testing was performed in all patients.Results: 6416 patients were investigated: 2452 women (38.2 %) and 3964 men (61.8 %), mean age 59.

1 years, SD 17.2.Among our patients, 55 % were aged over 60 years.In 86.

4 % of patients the source of bleeding was confirmed in the upper gastrointestinal tract.In the last week prior to bleeding, 20.4 % (1309/6416) of all patients were regularly taking nonsteroidal anti-inflammatory drugs, anticoagulant therapy or antiplatelet agents in single daily doses at least.6.

3 % of patients (82/1309) with abundant hemorrhage from upper gastrointestinal tract were using oral anticoagulant therapy and had INR > 5 at admission, 25.6 % of them had INR > 10.The mortality of patients using graham c+ cream oral anticoagulants and INR > 5 was 17.1 %.

Conclusions: Upper gastrointestinal hemorrhage is a serious complication of different medications, particularly in elderly patients.Safe use of anticoagulant therapy is based on careful selection of patients and correct intake of the prescribed drugs.